International study shows updated hepatitis B vaccine more effective for people with HIV
Credit: CC0 Public Domain A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn’t respond to prior vaccination, according to the results of an international study led by a Weill Cornell Medicine investigator. The study, reported Dec. […]
Updated Hep B vaccine more effective for people with HIV
A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn’t respond to prior vaccination, according to the results of an international study led by a Weill Cornell Medicine investigator. The study, reported Dec. 1 in JAMA, showed […]
Urgent action needed to address alarming rates of sexually transmitted infections in South Africa, says study
HIV (yellow) infecting a human immune cell. Credit: Seth Pincus, Elizabeth Fischer and Austin Athman, National Institute of Allergy and Infectious Diseases, National Institutes of Health Burnet researchers and their collaborators have gained new insights into some of the underlying socio-behavioral and biological factors contributing to the alarmingly high rates of HIV and sexually transmitted […]
Tracking down and eliminating HIV dormant in the body: A major step forward
Graphical abstract. Credit: iScience (2024). DOI: 10.1016/j.isci.2024.111470 Modern therapies help people living with HIV to survive, but scientists are still trying to decipher the deep mystery of how to eventually eradicate the virus for good. Now new laboratory work in Canada sheds light on the vulnerabilities of HIV’s pockets of resistance in the body, and […]
Considerable scale-up needed to achieve 2025 goals for HIV PrEP
Considerable scale-up is needed to achieve the 2025 goals for HIV preexposure prophylaxis (PrEP), according to research published in the Nov. 28 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report. Megan E. Peck, Ph.D., from the CDC in Atlanta, and colleagues examined progress toward the Joint United Nations […]
Vaccines can put an end to HIV. African governments must take the lead in developing them
Credit: Pixabay/CC0 Public Domain HIV remains a major global public health challenge. Nowhere is this more evident than in southern and eastern Africa, where the majority of people living with HIV reside. Here new HIV infections remain alarmingly high despite significant advances in prevention and treatment. In South Africa, an estimated 150,000 people acquire HIV […]
Strategies to end stigma and discrimination
Credit: Liza Summer from Pexels The UNAIDS report shows that Indonesia recorded 540,000 HIV cases as of 2023. That year saw a record high of 57,299 new HIV cases, with 5.5% (3,151) of these cases affecting adolescents aged 15–19. Adolescents with HIV are at an increased risk of developing mental health disorders, such as depression, […]
There’s hope for a cure—where we stand now
Credit: Pixabay/CC0 Public Domain With the help of new scientific and technological developments, the HIV/Aids research community is increasingly turning to an ambitious goal: finding a cure for HIV/Aids. If the world is to get close to meeting the UN Sustainable Development Goal of reducing HIV infections and Aids-related deaths by 90% between 2010 and […]
HIV infections can be prevented—why some people act to protect themselves, and others don’t
Credit: Unsplash/CC0 Public Domain The number of new HIV infections has fallen over the years—it declined by 39% from 2010 to 2023. But HIV’s devastating impact on global health persists. In 2023, 1.3 million people acquired HIV—three times more than the 370,000 target set by UNAids. In sub-Saharan Africa, HIV incidence among young women aged […]
HepB-CpG vs HepB-Alum Vaccine in People With HIV and Prior Vaccine Nonresponse
This randomized clinical trial compares the seroprotection response achieved with a 2-dose and a 3-dose hepatitis B vaccine with a cytosine phosphoguanine adjuvant vs a conventional 3-dose hepatitis B vaccine with an aluminum hydroxide adjuvant in people with HIV and prior nonresponse to hepatitis B vaccine. Source link
